• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过表达反义胰岛素样生长因子I RNA的免疫原性C6细胞治疗和预防大鼠胶质母细胞瘤

Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA.

作者信息

Trojan J, Johnson T R, Rudin S D, Ilan J, Tykocinski M L, Ilan J

机构信息

INSERM, Paris.

出版信息

Science. 1993 Jan 1;259(5091):94-7. doi: 10.1126/science.8418502.

DOI:10.1126/science.8418502
PMID:8418502
Abstract

Rat C6 glioma cells express insulin-like growth factor I (IGF-I) and form rapidly growing tumors in syngeneic animals. When transfected with an episome-based vector encoding antisense IGF-I complementary DNA, these cells lost tumorigenicity. Subcutaneous injection of IGF-I antisense-transfected C6 cells into rats prevented formation of both subcutaneous tumors and brain tumors induced by nontransfected C6 cells. The antisense-transfected cells also caused regression of established brain glioblastomas when injected at a point distal to the tumor. These antitumor effects result from a glioma-specific immune response involving CD8+ lymphocytes. Antisense blocking of IGF-I expression may reverse a phenotype that allows C6 glioma cells to evade the immune system.

摘要

大鼠C6胶质瘤细胞表达胰岛素样生长因子I(IGF-I),并在同基因动物中形成快速生长的肿瘤。当用编码反义IGF-I互补DNA的附加型载体转染时,这些细胞失去了致瘤性。将反义IGF-I转染的C6细胞皮下注射到大鼠体内,可阻止未转染的C6细胞诱导形成皮下肿瘤和脑肿瘤。当在肿瘤远端的一点注射时,反义转染的细胞还可使已形成的脑胶质母细胞瘤消退。这些抗肿瘤作用源于涉及CD8+淋巴细胞的胶质瘤特异性免疫反应。对IGF-I表达的反义阻断可能会逆转使C6胶质瘤细胞逃避免疫系统的表型。

相似文献

1
Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA.通过表达反义胰岛素样生长因子I RNA的免疫原性C6细胞治疗和预防大鼠胶质母细胞瘤
Science. 1993 Jan 1;259(5091):94-7. doi: 10.1126/science.8418502.
2
Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I.基于附加体的胰岛素样生长因子I反义cDNA转录对大鼠胶质母细胞瘤致瘤性的抑制
Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4874-8. doi: 10.1073/pnas.89.11.4874.
3
Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma.通过IGF-I三螺旋技术转化的人胶质瘤细胞表现出免疫和凋亡特征,这些特征决定了胶质母细胞瘤基因治疗的细胞选择。
Mol Pathol. 2001 Aug;54(4):230-9. doi: 10.1136/mp.54.4.230.
4
Correlation of glioma cell regression with inhibition of insulin-like growth factor 1 and insulin-like growth factor-binding protein-2 expression.胶质瘤细胞消退与胰岛素样生长因子1及胰岛素样生长因子结合蛋白-2表达抑制的相关性
Neuroendocrinology. 1997 Sep;66(3):203-11. doi: 10.1159/000127239.
5
Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors.表达胰岛素样生长因子-1(IGF-1)受体反义RNA的大鼠胶质母细胞瘤细胞无致瘤性,并可诱导野生型肿瘤消退。
Cancer Res. 1994 Apr 15;54(8):2218-22.
6
Alterations in tumorigenicity of embryonal carcinoma cells by IGF-I triple-helix induced changes in immunogenicity and apoptosis.IGF-I三螺旋诱导的免疫原性和凋亡变化导致胚胎癌细胞致瘤性的改变。
Life Sci. 2000 Dec 8;68(3):307-19. doi: 10.1016/s0024-3205(00)00936-x.
7
Inhibition of rat C6 glioblastoma tumor growth by expression of insulin-like growth factor I receptor antisense mRNA.通过表达胰岛素样生长因子I受体反义mRNA抑制大鼠C6胶质母细胞瘤肿瘤生长。
Cancer Immunol Immunother. 1996 Jan;42(1):64-8. doi: 10.1007/s002620050252.
8
Regression of C6 rat brain tumors by cells expressing an antisense insulin-like growth factor I receptor RNA.通过表达反义胰岛素样生长因子I受体RNA的细胞使C6大鼠脑肿瘤消退。
J Exp Ther Oncol. 1996 Nov;1(6):385-9.
9
Antisense insulin-like growth factor I transferred into a rat hepatoma cell line inhibits tumorigenesis by modulating major histocompatibility complex I cell surface expression.转入大鼠肝癌细胞系的反义胰岛素样生长因子I通过调节主要组织相容性复合体I细胞表面表达来抑制肿瘤发生。
Cancer Gene Ther. 1997 Sep-Oct;4(5):276-85.
10
IGF-I triple helix gene therapy of rat and human gliomas.大鼠和人类胶质瘤的胰岛素样生长因子-I三螺旋基因治疗
Rocz Akad Med Bialymst. 2003;48:18-27.

引用本文的文献

1
Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti-Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast Cancer.免疫和生长因子信号通路与乳腺癌患者抗I型胰岛素样生长因子受体方案的病理完全缓解相关。
Clin Cancer Res. 2025 Sep 4:OF1-OF11. doi: 10.1158/1078-0432.CCR-25-0553.
2
Anti-Gene IGF-I Vaccines in Cancer Gene Therapy: A Review of a Case of Glioblastoma.癌症基因治疗中的抗基因IGF-I疫苗:胶质母细胞瘤病例综述
Curr Med Chem. 2024;31(15):1983-2002. doi: 10.2174/0109298673237968231106095141.
3
New insights on the cardiovascular effects of IGF-1.
关于 IGF-1 对心血管影响的新见解。
Front Endocrinol (Lausanne). 2023 Feb 9;14:1142644. doi: 10.3389/fendo.2023.1142644. eCollection 2023.
4
Hallmarks of cancer: The insulin-like growth factors perspective.癌症的特征:胰岛素样生长因子视角
Front Oncol. 2022 Nov 21;12:1055589. doi: 10.3389/fonc.2022.1055589. eCollection 2022.
5
Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research.用于实验神经肿瘤学研究的大鼠和小鼠脑肿瘤模型。
J Neuropathol Exp Neurol. 2022 Apr 27;81(5):312-329. doi: 10.1093/jnen/nlac021.
6
Self-Assembly Protein Superstructures as a Powerful Chemodynamic Therapy Nanoagent for Glioblastoma Treatment.自组装蛋白质超结构作为一种用于胶质母细胞瘤治疗的强大化学动力疗法纳米药物
Nanomicro Lett. 2020 Jul 15;12(1):151. doi: 10.1007/s40820-020-00490-6.
7
Glioma Cells With Genetically Engineered IGF-I Receptor Downregulation Can Persist in the Brain in a Dormant State.基因工程下调胰岛素样生长因子-I受体的胶质瘤细胞可在脑内以休眠状态持续存在。
Front Oncol. 2020 Sep 23;10:555945. doi: 10.3389/fonc.2020.555945. eCollection 2020.
8
Manipulation of Metabolic Pathways and Its Consequences for Anti-Tumor Immunity: A Clinical Perspective.代谢途径的调控及其对抗肿瘤免疫的影响:临床视角。
Int J Mol Sci. 2020 Jun 4;21(11):4030. doi: 10.3390/ijms21114030.
9
C6 cell line: the gold standard in glioma research.C6细胞系:胶质瘤研究的金标准。
Hippokratia. 2018 Jul-Sep;22(3):105-112.
10
Therapeutic Targeting of the IGF Axis.IGF 轴的治疗靶向。
Cells. 2019 Aug 14;8(8):895. doi: 10.3390/cells8080895.